ERBB2 and breast cancer: Next, we found that one of the Treg signatures was significantly correlated with overall survival in all 4 sets, but the other Treg signature was only significant in the HER2+ and TNBC sets, suggesting that different Treg subsets may play different roles in breast cancer subtypes.